|
Volumn 9, Issue 3, 1999, Pages 167-175
|
Diabetic nephropathy in patients with Type II diabetes
|
Author keywords
Diabetic nephropathy; Diabetic nephropathy natural history; Diabetic nephropathy treatment; Type II diabetes
|
Indexed keywords
AMLODIPINE;
ANTIHYPERTENSIVE AGENT;
ATENOLOL;
CAPTOPRIL;
HYPOCHOLESTEROLEMIC AGENT;
INSULIN;
IRBESARTAN;
METFORMIN;
NIFEDIPINE;
PERINDOPRIL;
SULFONYLUREA;
CLINICAL TRIAL;
DIABETES CONTROL;
DIABETIC NEPHROPATHY;
DYSLIPIDEMIA;
GERMANY;
HEALTH CARE COST;
HISTORY;
HUMAN;
HYPERTENSION;
INSULIN DEPENDENT DIABETES MELLITUS;
KIDNEY FAILURE;
KIDNEY FUNCTION;
META ANALYSIS;
MICROALBUMINURIA;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PRIORITY JOURNAL;
PROTEIN RESTRICTION;
PROTEINURIA;
REVIEW;
RISK FACTOR;
SURVIVAL RATE;
UNITED STATES;
ALBUMINURIA;
DIABETES MELLITUS, TYPE 2;
DIABETIC NEPHROPATHIES;
DISEASE PROGRESSION;
HUMANS;
KIDNEY FAILURE, CHRONIC;
PROTEINURIA;
RISK FACTORS;
|
EID: 0033394770
PISSN: 09248455
EISSN: None
Source Type: Journal
DOI: 10.1023/A:1008378600115 Document Type: Review |
Times cited : (3)
|
References (73)
|